Pruco Life Insurance Company v. Wilmington Trust Company

721 F.3d 1, 2013 WL 3242809, 2013 U.S. App. LEXIS 13317
CourtCourt of Appeals for the First Circuit
DecidedJune 28, 2013
Docket12-2227, 12-2228
StatusPublished
Cited by22 cases

This text of 721 F.3d 1 (Pruco Life Insurance Company v. Wilmington Trust Company) is published on Counsel Stack Legal Research, covering Court of Appeals for the First Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Pruco Life Insurance Company v. Wilmington Trust Company, 721 F.3d 1, 2013 WL 3242809, 2013 U.S. App. LEXIS 13317 (1st Cir. 2013).

Opinion

LYNCH, Chief Judge.

Wilmington Trust Company and Jay L’Archevesque, co-trustees of the Paul E. L’Archevesque Special Revocable Trust-2006, challenge the district court’s grant of summary judgment to Pruco Life Insurance Company on Pruco’s claim for a judgment of mutual rescission of a life insurance policy, owned by the trust, on the life of Paul L’Archevesque.

This case turns on a limited set of material facts. Pruco sought rescission of the policy after it discovered that the policy application had contained material misrepresentations about the health of the insured. It tendered to Wilmington a check in the amount of the policy premiums paid (plus interest), along with a letter clearly stating that the purpose of the check was to effect rescission of the policy. Under the trust agreement, Wilmington had ceded decisionmaking authority to Coventry Capital I LLC, a premium financing company, which was acting as the servicing agent for a bank that had taken a security interest in the policy. Wilmington accordingly forwarded the check and the letter to Coventry, and after three weeks of investigation and consultation with in-house counsel, Coventry sent the check back to Wilmington with instructions to cash it. Wilmington did so. At no time before or since has anyone attempted to return the money to Pruco.

Under these circumstances, the district court concluded that, as a matter of law, a mutual rescission had taken place, and Pruco was entitled to a judgment declaring the policy void ab initio. In an effort to avoid this conclusion, Wilmington and Jay L’Archevesque raise a series of arguments that attempt to obscure the relevant facts. We reject these arguments and affirm the district court’s judgment.

I.

In the fall of 2005, on the advice of his accountant, Paul L’Archevesque met with an insurance broker, Vincent Passananti, to discuss purchasing a life insurance policy. Passananti explained to Paul 1 that he could purchase this insurance using non-recourse premium financing: Paul would take a loan to pay the premiums, and when the loan matured he could sell the policy on the open market, using the proceeds to pay off the loan and retaining any excess proceeds for himself. Paul testified that his intention was to sell the policy after about two years.

To obtain the loan, Passananti submitted Paul’s medical records to Coventry, a company with which Passananti had a contract to produce premium financing transactions. At least one of these records noted that Paul had been experiencing some memory loss. After conducting its own medical underwriting, Coventry approved the premium financing on January 4, 2006, and arranged for a loan through LaSalle Bank.

Later that month, Paul created two trusts that would be used to take out the premium finance loan and eventually hold *4 the life insurance policy. The first was the Paul E. L’Archevesque Special Trust-2006, of which Jay was the sole trustee. The second was the Paul E. L’Archevesque Special Revocable Trus1>-2006, of which the first trust was the settlor and Jay and Wilmington were co-trustees. Wilmington is a professional trust company that acts as trustee for approximately 800 trusts in connection with Coventry’s premium finance loans. The two trusts and Wilmington then entered into a supplement to the trust agreement, which provided, inter alia, that Wilmington would create a sub-trust to enter into the loan agreement with LaSalle.

The sub-trust agreement provided that Jay and Wilmington would perform their duties as trustees at the direction of La-Salle or its designees for the duration of the loan. The note and security agreement between the sub-trust and LaSalle stated that Coventry would act as La-Salle’s servicing agent and confirmed that Jay and Wilmington would follow Coventry’s instructions until LaSalle decided otherwise. Further, Jay and Paul each signed a power of attorney designating Coventry as his attorney-in-fact for purposes of, respectively, the sub-trust and the life insurance policy.

Meanwhile, Passananti began making inquiries on Paul’s behalf to a number of life insurance companies, including Pruco. He sent an informal inquiry to Pruco on January 24, 2006. Pursuant to a HIPAA authorization signed by Paul, Passananti also gathered and sent Paul’s medical records to Pruco and other insurers. The parties vigorously contest which medical records were sent to Pruco and when. It is at least common ground, however, that at no time before or during its underwriting process did Pruco receive a copy of an earlier letter from a neurologist to Paul’s primary care doctor, dated January 11, 2006, which stated that the neurologist believed Paul had “[p]robable mild Alzheimer’s disease” and that Paul had been given a medication, Razadyne ER, used to treat Alzheimer’s disease. It is uncontested that Paul actually received this medication. Further, the inquiry Passananti sent to Pruco included a medical exam report that also did not mention memory loss or Alzheimer’s disease. While the records that Pruco undis-putedly received did show that Paul had at times complained of depression and dizziness, they did not reflect any probable or actual diagnoses that Pruco would consider “materially adverse” health conditions. Alzheimer’s disease or other forms of dementia would have been considered material.

Based on the information it had received, Pruco issued a tentative offer of life insurance, subject to the receipt of additional items, including a formal application. On February 16, 2006, Paul, through Pas-sananti, submitted an application to Pruco for a $10 million life insurance policy (an amount that was later increased to $15 million). The application contained a number of yes-or-no questions about the insured’s medical history; Paul instructed Passananti to “mark ‘No’ on everything.” The parties do not dispute that some of these “no” answers constituted misrepresentations. Specifically, Paul answered “no” to the question of whether he had “been diagnosed with or treated for ... any disorder of the brain or nervous system,” even though he had recently complained of memory problems and received a diagnosis of “[p]robable mild Alzheimer’s disease” along with medication to treat that condition. He also answered “no” to the question of whether he was “currently taking any prescription medications,” even though he had been given the Razadyne.

On March 7, 2006, Pruco issued a $15 million policy on Paul’s life. The policy *5 was issued to Jay as trustee of the Special Trust-2006. Wilmington, as co-trustee of the Special Revocable Trust-2006, was added as an owner and beneficiary of the policy on March 21, 2006. LaSalle then took a security interest in the policy as collateral for its premium finance loan.

Approximately a year and a half later, in the fall of 2007, Pruco received an inquiry from Coventry relating to the policy. This inquiry suggested to Pruco that Paul intended to sell the policy, which raised the underwriting manager’s suspicion that “something else was going on” with Paul’s health. Pruco then ordered Paul’s updated medical records, which revealed the previously undisclosed information about Paul’s memory loss, “[pjrobable mild Alzheimer’s” diagnosis, and Razadyne prescription.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Kimber v. Harker
S.D. California, 2024
Smith v. Mesa, City of
D. Arizona, 2023
Dixon-Tribou v. McDonough
86 F.4th 453 (First Circuit, 2023)
United States v. Ruiz
Second Circuit, 2023
HENDERSON v. United States
S.D. Indiana, 2022
Lahens v. AT&T Mobility Puerto Rico, Inc
28 F.4th 325 (First Circuit, 2022)
Player's Poker Club, Inc.
C.D. California, 2022
Avalanche IP, LLC v. FAM, LLC
D. Massachusetts, 2021
United States v. Frank Agrama
C.D. California, 2020
Sierra-Lopez v. Pagels
E.D. Wisconsin, 2020
Costello v. Molari, Inc.
D. Massachusetts, 2019
United States v. Moore
Second Circuit, 2019
Barth v. City of Peabody
D. Massachusetts, 2018

Cite This Page — Counsel Stack

Bluebook (online)
721 F.3d 1, 2013 WL 3242809, 2013 U.S. App. LEXIS 13317, Counsel Stack Legal Research, https://law.counselstack.com/opinion/pruco-life-insurance-company-v-wilmington-trust-company-ca1-2013.